Two Sigma Securities’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
GIM
BPC
CS
AWA
PVI
BPCE
Two Sigma Securities's SOPH Position: Q2 2023 in Review
Two Sigma Securities sold out of SOPHiA GENETICS (SOPH) in Q2 2023, closing a stake of 18,129 shares — an estimated $90.1K sold.
Two Sigma Securities first reported a position in SOPH in Q1 2023 and held it in 1 quarter. The position peaked at $90.1K in Q1 2023. 34 funds tracked by Wall St. Rank hold SOPH as of Q2 2023.
- Two Sigma Securities reported no remaining SOPHiA GENETICS position as of Q2 2023 after selling out during the quarter.
- Two Sigma Securities sold 18,129 SOPHiA GENETICS shares in Q2 2023, an estimated $90.1K.
- Two Sigma Securities first reported a position in SOPHiA GENETICS in Q1 2023 and held it in 1 quarter.
- Two Sigma Securities's SOPHiA GENETICS position peaked at $90.1K in Q1 2023.
- 34 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2023.
Based on Two Sigma Securities's 13F filing for Q2 2023, filed 14 Aug 2023.